Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Stock Report

Market Cap: CN¥4.3b

Zhejiang Shouxiangu Pharmaceutical Balance Sheet Health

Financial Health criteria checks 5/6

Zhejiang Shouxiangu Pharmaceutical has a total shareholder equity of CN¥2.2B and total debt of CN¥553.9M, which brings its debt-to-equity ratio to 24.8%. Its total assets and total liabilities are CN¥3.1B and CN¥822.6M respectively. Zhejiang Shouxiangu Pharmaceutical's EBIT is CN¥165.5M making its interest coverage ratio -5. It has cash and short-term investments of CN¥1.2B.

Key information

24.8%

Debt to equity ratio

CN¥553.92m

Debt

Interest coverage ratio-5x
CashCN¥1.16b
EquityCN¥2.23b
Total liabilitiesCN¥822.58m
Total assetsCN¥3.05b

Recent financial health updates

No updates

Recent updates

We Think That There Are More Issues For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Than Just Sluggish Earnings

Nov 04
We Think That There Are More Issues For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Than Just Sluggish Earnings

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

Financial Position Analysis

Short Term Liabilities: 603896's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥378.6M).

Long Term Liabilities: 603896's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥443.9M).


Debt to Equity History and Analysis

Debt Level: 603896 has more cash than its total debt.

Reducing Debt: 603896's debt to equity ratio has increased from 1.9% to 24.8% over the past 5 years.

Debt Coverage: 603896's debt is well covered by operating cash flow (47.5%).

Interest Coverage: 603896 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies